HTML
-
The human hepatoma HepG2.2.15 and HuH-7 cell lines were obtained from the China Center for Type Culture Collection (CCTCC). Cells were cultured in Dulbecco's modified Eagle's Medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and antibiotics (100 units/mL penicillin and 100 μg/mL streptomycin, Gibco Life Technologies, USA) at 37 ℃ in a 5% CO2 incubator.
The pCH-9/3091 construct containing 1.1 copies of the HBV genome was kindly provided by Prof. Michael Nassal (University of Freiburg) and transfected into HuH-7 cells. Briefly, HuH-7 cells at a density of 2 × 105 cells/well were seeded in 24-well plates, cultured for 24 h, and then transfected with 0.8 μg of pCH-9/3091 using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions.
-
Quercetin dihydrate was purchased from Calbiochem (German). Three clinically used anti-HBV drugs, ETV (entecavir-triphosphate, Moravek Biochemicals, USA), 3TC (lamivudine, Sigma-Aldrich, USA) and Ade (adefovir, Sigma-Aldrich, USA), were used as positive controls. And all compounds were dissolved in dimethyl sulfoxide (DMSO), and then diluted into different concentration. HepG2.2.15 and HuH-7 cells were plated into 24-well plates at a density of 2 × 105 cells/well, cultured or transfected with pCH-9/3091. After incubation for 24 h, the media was gently aspirated and 1 mL of complete media with different concentration of compounds was replaced in each well. The final concentration of DMSO in each well was 0.3%. Treatment with 30 nmol/L ETV and 0.3% DMSO served as positive and negative (non-drug) controls. The treatment day was designated as day 0, and the culture media were replaced every 24 h with fresh medium containing the respective treatments. Supernatants and cells were collected at the indicated time points for further analysis.
-
The toxicity of quercetin against the cell lines was determined using the water-soluble tetrazolium ([WST]-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt]) assay with the cell counting kit-8 (CCK-8, Dojindo Labora-tories, Japan) following the manufacturer's instruction. Briefly, HepG2.2.15 and HuH-7 cells (1 × 104 cells/well) were cultured in 96-well plates, treated with quercetin (1, 10, 25, 50, 100, and 200 μmol/L) for 4 days, and the media were replaced with fresh media containing quercetin daily. On the last day, 10 μL of WST-8 solution was added to each well followed by incubation at 37 ℃ for 2 h, and then the optical density (OD) was measured at 450 nm. Each experiment was performed in triplicate and the cell viability was normalized to the control sample.
-
To quantify the HBV antigen secretion, the supernatants of drug-treated cells were collected at the indicated time points, and the HBsAg and HBeAg levels were determined using a commercial ELISA kit (Kehua Bio-engineering, China). The results were normalized to the control sample.
-
Intracellular nucleocapsid-associated viral DNA was extracted from HepG2.2.15 or transfected HuH-7 cells as described previously (Feng et al., 2013). In brief, 2 × 105 cells were lysed in 200 μL lysis buffer containing 50 mmol/L Tris-hydrochloride (HCl) pH 7.5, 140 mmol/ L sodium chloride (NaCl), and 0.5% NP-40. After centrifugation, the supernatants were incubated with 20 U DNase I (TaKaRa, Japan) and 2 μL RNase A (TaKaRa) at 37 ℃ for 2 h, to completely digest the non-encapsulated DNA and RNA. Then, 200 mmol/L proteinase K (Tiangen, China) was added to degrade the core particles. After extraction and precipitation with phenol-chloroform and ethanol, respectively, the viral DNA was dissolved in Tris-ethylenediaminetetraacetic acid (EDTA, TE) buffer. Extracellular viral DNA was extracted from 200 μL of medium using the TIANamp Virus DNA/RNA kit (Tiangen) according to the manufacturer's instructions.
Total RNA was extracted from HepG2.2.15 and transfected HuH-7 cells using TRIzol reagent (Invitrogen) and reverse transcribed to cDNA using a PrimeScript RT reagent kit (TaKaRa). The q-PCR was performed with the SYBR Premix Ex Taq Ⅱ (TaKaRa) using a LightCycler 96 Real-Time PCR system (Roche, Swizerl and). The cycling program was run at 95 ℃ for 5 min, followed by 45 cycles at 95 ℃ for 10 s, 60 ℃ for 10 s, and 72 ℃ for 10 s. The primers used are listed in Table 1.
Table 1. Primers
-
All results of this study are presented as mean ± standard deviation (SD) of at least three independent experiments. Differences were considered statistically significant when P < 0.05 and P < 0.01 using unpaired twotailed Student's t-tests.